You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 266 No. 18, November 13, 1991 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Assessing risk for pelvic inflammatory disease and its sequelae

A. E. Washington, S. O. Aral, P. Wolner-Hanssen, D. A. Grimes and K. K. Holmes
Center for Reproductive Health Policy Research, University of California School of Medicine, San Francisco 94143.

To assess the risk for pelvic inflammatory disease (PID), a practitioner must evaluate the likelihood that a woman has PID or will be exposed to a sexually transmitted disease causing PID. Successful risk assessment depends on accurate information about variables influencing risk of PID. To determine the current state of knowledge about PID risk variables, we examined data in published reports. Data on each risk variable were scrutinized to discern which link(s) in the PID risk chain it affects (acquisition of a sexually transmitted disease, development of PID, or development of PID sequelae) and whether it is a risk marker or a risk factor. Most PID risk variables, particularly sexual behaviors, are associated with acquisition of a sexually transmitted disease, rather than development of PID itself. With the exception of age, demographic and social indicators of risk appear to be risk markers, while contraceptive practices appear more often to be risk factors than risk markers. Additional data are needed for most PID risk variables confidently to categorize them as risk factors. Enough information is available, however, to begin assessing risk for PID, so that appropriate counseling can ensue and timely diagnosis can be made.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk factors associated with pelvic inflammatory disease
Simms et al.
Sex. Transm. Infect. 2006;82:452-457.
ABSTRACT | FULL TEXT  

Copper IUDs, infection and infertility
DTB 2002;40:67-69.
ABSTRACT | FULL TEXT  

Assessment of risk for pelvic inflammatory disease in an urban sexual health population
Marks et al.
Sex. Transm. Infect. 2000;76:470-473.
ABSTRACT | FULL TEXT  

Pelvic inflammatory disease epidemiology: what do we know and what do we need to know?
Simms and Stephenson
Sex. Transm. Infect. 2000;76:80-87.
FULL TEXT  

Human Leukocyte Antigen Class II DQ Alleles Associated With Chlamydia trachomatis Tubal Infertility
COHEN et al.
Obstet Gynecol 2000;95:72-77.
ABSTRACT | FULL TEXT  

Management of genital Chlamydia trachomatis infections
DTB 1994;32:87-88.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.